Elan to return $1 billion to shareholders from multiple sclerosis drug sale
DUBLIN (Reuters) - Irish drugmaker Elan will return $1 billion to shareholders, giving them an immediate boost from the sale of its stake in multiple ...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/9jqCJ5u-Rbo/us-elan-buyback-idUSBRE91L08A20130222
No comments:
Post a Comment